Home LiteratureArticle Details
PMID: 16272493 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Population structure and properties of Candida albicans, as determined by multilocus sequence typing.

Journal of clinical microbiology ·Vol. 43 ·No. 11 ·2005-11-00 ·Pages 5601-13

Tavanti A, Davidson AD, Fordyce MJ, Gow NA, Maiden MC, Odds FC

Abstract

We submitted a panel of 416 isolates of Candida albicans from separate sources to multilocus sequence typing (MLST). The data generated determined a population structure in which four major clades of closely related isolates were delineated, together with eight minor clades comprising five or more isolates. By Fisher's exact test, a statistically significant association was found between particular clades and the anatomical source, geographical source, ABC genotype, decade of isolation, and homozygosity versus heterozygosity at the mating type-like locus (MTL) of the isolates in the clade. However, these associations may have been influenced by confounding variables, since in a univariate analysis of variance, only the clade associations with ABC type and anatomical source emerged as statistically significant, providing the first indication of possible differences between C. albicans strain type clades and their propensity to infect or colonize different anatomical locations. There were no significant differences between clades with respect to distributions of isolates resistant to fluconazole, itraconazole, or flucytosine. However, the majority of flucytosine-resistant isolates belonged to clade 1, and these isolates, but not flucytosine-resistant isolates in other clades, bore a unique mutation in the FUR1 gene that probably accounts for their resistance. A significantly higher proportion of isolates resistant to fluconazole, itraconazole, and flucytosine were homozygous at the MTL, suggesting that antifungal pressure may trigger a common mechanism that leads both to resistance and to MTL homozygosity. The utility of MLST for determining clade assignments of clinical isolates will form the basis for strain selection for future research into C. albicans virulence.

MeSH Terms
Analysis of Variance Antifungal Agents/pharmacology Blood/microbiology Candida albicans/classification,drug effects,genetics Candidiasis/microbiology Drug Resistance, Fungal/genetics Europe Female Genes, Fungal/genetics Humans Mycological Typing Techniques North America Oropharynx/microbiology Phylogeny Sequence Analysis Species Specificity Vagina/microbiology
Chemicals
Antifungal Agents
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Tavanti Arianna
Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom.
Davidson Amanda D
Fordyce Mark J
Gow Neil A R
Maiden Martin C J
Odds Frank C
References (48)
48 references, click to expand
  1. Long-term laboratory preservation of pathogenic yeasts in water.
    J Med Vet Mycol. 1991;29(6):413-5 PMID: 1815033
  2. Non-identity and authentication of two major reference strains of Candida albicans.
    J Med Vet Mycol. 1991;29(4):255-61 PMID: 1682436
  3. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.
    Clin Infect Dis. 1994 Feb;18(2):240-2 PMID: 8161633
  4. Detection of amphotericin B-resistant Candida isolates in a broth-based system.
    Antimicrob Agents Chemother. 1995 Apr;39(4):906-9 PMID: 7785993
  5. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.
    Antimicrob Agents Chemother. 1995 Sep;39(9):2051-60 PMID: 8540715
  6. Physiological traits associated with success of Candida albicans strains as commensal colonizers and pathogens.
    J Clin Microbiol. 1995 Nov;33(11):2920-6 PMID: 8576346
  7. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Antimicrob Agents Chemother. 1995 Nov;39(11):2378-86 PMID: 8585712
  8. Comparative analysis of genetic variability among Candida albicans isolates from different geographic locales by three genotypic methods.
    J Clin Microbiol. 1997 Jun;35(6):1332-6 PMID: 9163439
  9. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
    Antimicrob Agents Chemother. 1997 Jul;41(7):1482-7 PMID: 9210670
  10. Prevalence of Candida dubliniensis isolates in a yeast stock collection.
    J Clin Microbiol. 1998 Oct;36(10):2869-73 PMID: 9738035
  11. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea.
    J Clin Microbiol. 1999 Feb;37(2):417-21 PMID: 9889231
  12. Evidence for a general-purpose genotype in Candida albicans, highly prevalent in multiple geographical regions, patient types and types of infection.
    Microbiology. 1999 Sep;145 ( Pt 9):2405-13 PMID: 10517593
  13. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2.
    Eukaryot Cell. 2004 Dec;3(6):1639-52 PMID: 15590837
  14. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III.
    J Clin Microbiol. 2005 Jan;43(1):284-92 PMID: 15634984
  15. Genetic structure of typical and atypical populations of Candida albicans from Africa.
    Fungal Genet Biol. 1999 Nov;28(2):107-25 PMID: 10587473
  16. Evolution of drug resistance in experimental populations of Candida albicans.
    J Bacteriol. 2000 Mar;182(6):1515-22 PMID: 10692355
  17. Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates.
    Mol Microbiol. 2000 May;36(4):856-65 PMID: 10844673
  18. [Genetic structure of geographically different populations of candida albicans].
    Mycoses. 2000;43 Suppl 2:51-6 PMID: 11291578
  19. Evidence for a more recently evolved clade within a Candida albicans North American population.
    Microbiology. 2001 Jun;147(Pt 6):1687-92 PMID: 11390700
  20. Database-driven multi locus sequence typing (MLST) of bacterial pathogens.
    Bioinformatics. 2001 Nov;17(11):1077-83 PMID: 11724739
  21. MEGA2: molecular evolutionary genetics analysis software.
    Bioinformatics. 2001 Dec;17(12):1244-5 PMID: 11751241
  22. Candida africana sp. nov., a new human pathogen or a variant of Candida albicans?
    Mycoses. 2001 Dec;44(11-12):437-45 PMID: 11820255
  23. Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals a new clade in South Africa.
    J Clin Microbiol. 2002 Mar;40(3):826-36 PMID: 11880401
  24. Usefulness of multilocus sequence typing for characterization of clinical isolates of Candida albicans.
    J Clin Microbiol. 2002 Apr;40(4):1290-7 PMID: 11923347
  25. Homozygosity at the Candida albicans MTL locus associated with azole resistance.
    Microbiology. 2002 Apr;148(Pt 4):1061-72 PMID: 11932451
  26. Population genomics of drug resistance in Candida albicans.
    Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9284-9 PMID: 12089321
  27. Ca3 fingerprinting of Candida albicans bloodstream isolates from the United States, Canada, South America, and Europe reveals a European clade.
    J Clin Microbiol. 2002 Aug;40(8):2729-40 PMID: 12149321
  28. Stability of allelic frequencies and distributions of Candida albicans microsatellite loci from U.S. population-based surveillance isolates.
    J Clin Microbiol. 2003 Mar;41(3):1316-21 PMID: 12624076
  29. Drug resistance is not directly affected by mating type locus zygosity in Candida albicans.
    Antimicrob Agents Chemother. 2003 Apr;47(4):1207-12 PMID: 12654648
  30. Optimization and validation of multilocus sequence typing for Candida albicans.
    J Clin Microbiol. 2003 Aug;41(8):3765-76 PMID: 12904388
  31. Candida albicans clades.
    FEMS Immunol Med Microbiol. 2003 Oct 24;39(1):1-7 PMID: 14556989
  32. Multi-locus sequence typing: a tool for global epidemiology.
    Trends Microbiol. 2003 Oct;11(10):479-87 PMID: 14557031
  33. Collaborative consensus for optimized multilocus sequence typing of Candida albicans.
    J Clin Microbiol. 2003 Nov;41(11):5265-6 PMID: 14605179
  34. Flucytosine resistance is restricted to a single genetic clade of Candida albicans.
    Antimicrob Agents Chemother. 2004 Jan;48(1):262-6 PMID: 14693548
  35. Mating-type locus homozygosis, phenotypic switching and mating: a unique sequence of dependencies in Candida albicans.
    Bioessays. 2004 Jan;26(1):10-20 PMID: 14696036
  36. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.
    Clin Microbiol Infect. 2004 Mar;10 Suppl 1:11-23 PMID: 14748799
  37. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data.
    J Bacteriol. 2004 Mar;186(5):1518-30 PMID: 14973027
  38. The diploid genome sequence of Candida albicans.
    Proc Natl Acad Sci U S A. 2004 May 11;101(19):7329-34 PMID: 15123810
  39. Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans.
    Antimicrob Agents Chemother. 2004 Jun;48(6):2223-7 PMID: 15155225
  40. Multilocus sequence typing of Candida albicans: strategies, data exchange and applications.
    Infect Genet Evol. 2004 Sep;4(3):243-52 PMID: 15450203
  41. Molecular mechanisms of primary resistance to flucytosine in Candida albicans.
    Antimicrob Agents Chemother. 2004 Nov;48(11):4377-86 PMID: 15504867
  42. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.
    Am J Med. 1983 Jan 24;74(1B):23-9 PMID: 6295149
  43. Analysis of Candida albicans phenotypes from different geographical and anatomical sources.
    J Clin Microbiol. 1983 Oct;18(4):849-57 PMID: 6355164
  44. Outbreak of systemic Candida albicans in intensive care unit caused by cross infection.
    Br Med J (Clin Res Ed). 1985 Mar 9;290(6470):746-8 PMID: 3918738
  45. Unique phenotype of opaque cells in the white-opaque transition of Candida albicans.
    J Bacteriol. 1987 Dec;169(12):5579-88 PMID: 3316187
  46. Carriage of Candida species and C albicans biotypes in patients undergoing chemotherapy or bone marrow transplantation for haematological disease.
    J Clin Pathol. 1989 Dec;42(12):1259-66 PMID: 2693492
  47. Reproducibility and indices of discriminatory power of microbial typing methods.
    J Clin Microbiol. 1990 Sep;28(9):1903-5 PMID: 2229371
  48. Isogenic strain construction and gene mapping in Candida albicans.
    Genetics. 1993 Jul;134(3):717-28 PMID: 8349105
Article Info
Journal
Journal of clinical microbiology
Abbr.
J Clin Microbiol
ISSN
0095-1137
Published
2005-11-00
Pages
5601-13
Language
English
Region
United States
NLM ID
7505564
PMCID
PMC1287804
Subset
IM
Grants
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]